Global Uro-Gynecological Surgical Devices Market – Industry Trends and Forecast to 2031

Análisis y tamaño del mercado de dispositivos quirúrgicos uroginecológicos

Las cirugías mínimamente invasivas (CMI) desempeñan un papel crucial en el mercado de dispositivos quirúrgicos uroginecológicos al ofrecer alternativas menos invasivas a las cirugías abiertas tradicionales. Estos procedimientos utilizan dispositivos especializados como laparoscopios, sistemas quirúrgicos robóticos e instrumentos en miniatura diseñados para una manipulación precisa en espacios reducidos como la región pélvica. La CMI en uroginecología reduce el trauma quirúrgico, el dolor posoperatorio y los tiempos de recuperación en comparación con las cirugías abiertas, lo que da lugar a estancias hospitalarias más cortas y un retorno más rápido a las actividades normales de los pacientes.

El tamaño del mercado global de dispositivos quirúrgicos uroginecológicos se valoró en USD 26,76 mil millones en 2023 y se proyecta que alcance los USD 48,73 mil millones para 2031, con una CAGR del 7,78% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado       

Definición de mercado

Los dispositivos quirúrgicos uroginecológicos son instrumentos y equipos especializados que se utilizan en procedimientos quirúrgicos relacionados con la urología y la ginecología. Estos dispositivos están diseñados para tratar afecciones como la incontinencia urinaria, el prolapso de los órganos pélvicos y otros trastornos que afectan el suelo pélvico femenino. Incluyen herramientas para cirugías mínimamente invasivas, procedimientos de diagnóstico e intervenciones terapéuticas destinadas a mejorar la salud pélvica y restablecer la función anatómica normal.

Dinámica del mercado de dispositivos quirúrgicos uroginecológicos

Conductores                                                                                          

• Mayor concienciación del consumidor

A medida que más mujeres se informan sobre los trastornos uroginecológicos y las opciones de tratamiento disponibles, es más probable que busquen ayuda médica. Esta concienciación se ve impulsada por las campañas de salud, el mejor acceso a la información a través de Internet y los grupos de apoyo. En consecuencia, la demanda de intervenciones quirúrgicas y dispositivos médicos avanzados aumenta a medida que más mujeres optan por estos tratamientos para mejorar su calidad de vida. Esta mayor concienciación también reduce el estigma asociado con los problemas uroginecológicos, lo que fomenta el diagnóstico y el tratamiento oportunos.

• Creciente población de personas mayores

La creciente población de edad avanzada es más propensa a padecer afecciones como la incontinencia urinaria y el prolapso de los órganos pélvicos. A medida que aumenta el número de personas mayores, aumenta la prevalencia de estos trastornos, lo que genera una mayor demanda de intervenciones quirúrgicas. Además, el debilitamiento de los músculos del suelo pélvico relacionado con la edad requiere reparaciones quirúrgicas, lo que impulsa la necesidad de dispositivos quirúrgicos especializados. El mejor acceso a la atención médica y una mayor esperanza de vida contribuyen aún más al crecimiento del mercado, ya que cada vez más pacientes de edad avanzada buscan tratamientos efectivos para problemas uroginecológicos.

Oportunidades

• Creciente gasto en atención sanitaria

El aumento del gasto permite a los centros sanitarios invertir en equipos de última generación, incluidos dispositivos quirúrgicos uroginecológicos avanzados, como sistemas robóticos, laparoscopios e instrumentos especializados. Esta inversión mejora la capacidad de los hospitales y las clínicas para ofrecer cirugías mínimamente invasivas , que son las preferidas por sus tiempos de recuperación reducidos y mejores resultados para los pacientes. Además, el mayor gasto sanitario apoya la investigación y el desarrollo en el campo, lo que conduce a la innovación en técnicas quirúrgicas y tecnología de dispositivos.

• Innovaciones tecnológicas en aumento

Technological innovations advances surgical techniques and enhancing patient outcomes. Key innovations include the development of robotic-assisted surgery systems such as da Vinci Surgical System, which offer greater precision and control in complex uro-gynecological procedures. Imaging technologies such as 3D laparoscopy and intraoperative ultrasound improve visualization and surgical planning, reducing risks and improving surgical accuracy. Additionally, advancements in biomaterials for vaginal meshes and slings enhance durability and biocompatibility, improving long-term outcomes for patients.

Restraints/Challenges

• High Initial Costs

The advanced technology and specialized nature of these devices often result in substantial upfront expenses for healthcare facilities and providers. This can limit adoption rates, especially in regions with constrained healthcare budgets or where reimbursement for such procedures is inadequate. Additionally, the cost of maintenance, training, and updates further adds to the financial burden. High costs may deter smaller healthcare facilities from investing in state-of-the-art equipment, leading to disparities in access to advanced surgical treatments.

• Lack of Skilled Labour

Advanced surgical procedures and the use of sophisticated devices require specialized training and expertise among healthcare professionals. However, there is often a shortage of trained surgeons, nurses, and support staff proficient in operating these technologies effectively. This shortage can limit the adoption of minimally invasive surgeries and new surgical devices, as healthcare facilities may struggle to find and retain qualified personnel. Additionally, inadequate training programs and educational resources for uro-gynecological surgeries can further exacerbate the skills gap, hindering the widespread implementation and utilization of advanced surgical techniques.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Uro-Gynecological Surgical Devices Market Scope

The market is segmented on the basis product type, disease specific surgeries and procedure. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Uro- Gynaecological Surgical Devices
  • Urethral Stents
  • Sling and Suspension Devices
  • Endometrial Ablation Devices
  • Gynaecological Surgery Devices
• Trocars
  • Curettage Systems
  • Tubal Occlusion Systems
• Endoscopes
  • Cytoscope
  • Laparoscopes
  • Falloposcope
  • Fluid Management Systems

Disease Specific Surgeries

• Pelvic Organ Prolapse
• Urinary Incontinence
• Others

Basis of Procedure

• Dilation and Curettage Procedure
• Uterine Balloon Therapy
• Hysteroscopy Procedure
• Tubal Ligation Procedure
• Myomectomy Procedure

Uro-Gynecological Surgical Devices Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product type, disease specific surgeries and procedure as referenced above.      

The countries covered in the market report are the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

North America dominates the market due to the region has a significant elderly population, which drives demand for treatments related to uro-gynecological conditions such as pelvic organ prolapse and urinary incontinence. This demographic trend creates a substantial market for surgical devices designed to address these issues. Additionally, North America benefits from advanced healthcare infrastructure and higher healthcare spending per capita, facilitating greater adoption of surgical interventions and innovative medical technologies. These factors combined contribute to the region's leadership in the development, adoption, and market share of uro-gynecological surgical devices compared to other global regions.

Asia-Pacific is expected to experience substantial growth in the market due to increasing awareness and healthcare infrastructure development. Rising incidences of urological and gynecological disorders among the population, coupled with growing healthcare expenditure and advancements in surgical technologies, are key drivers. Increased adoption of minimally invasive procedures and rising healthcare access in countries such as China, India, and Japan are further contributing factors. Market expansion is also supported by government initiatives promoting women's health and increasing investments by healthcare providers in advanced surgical equipment and techniques across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Uro-Gynecological Surgical Devices Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Boston Scientific Corporation (U.S.)
• Stryker (U.S.)
• Gyrus ACMI (U.S.)
• Cook (U.S.)
• CooperSurgical Inc. (U.S.)
• Millennium Surgical (U.S.)
• Narang Medical Limited (India)
• Medtronic (U.S.)
• Surgical Holdings (U.K.)
• MEDGYN PRODUCTS, INC. (U.S.)
• Sklar Surgical Instruments (U.S.)
• KLS Martin Group (Germany)
• Richard Wolf GmbH (Germany)
• KARL STORZ SE & Co. KG (Germany)
• Olympus Corporation (Japan)
• Johnson & Johnson Services, Inc. (U.S.)
• B. Braun SE (Germany)

SKU-63293